By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Exosome Diagnostics 

1585 Broadway

New York  New York  10036  U.S.A.
Phone: n/a Fax: n/a



Company News
Exosome Diagnostics Presents Data Demonstrating Ability To Detect EML4-ALK Fusion Transcripts On Exosomal RNA In Patients With Non-Small Cell Lung Cancer 4/20/2015 11:06:56 AM
Exosome Diagnostics Announces Positive Results From Initial Clinical Study Of Novel Prostate Cancer Liquid Biopsy 2/26/2015 10:39:15 AM
Exosome Diagnostics Seeks $25 Million to Commercialize Liquid Biopsies 1/28/2015 6:30:30 AM
Exosome Diagnostics And The Addario Lung Cancer Medical Institute (ALCMI) Announce Collaboration To Accelerate Development Of Plasma-Based Lung Cancer Diagnostics 1/9/2015 10:51:26 AM
Exosome Diagnostics Presents Data On Molecular Biofluid-Based Mutation Detection In Cancer 11/20/2014 11:07:30 AM
Exosome Diagnostics Demonstrates Superior Mutation Detection Utilizing Combined Exosomal RNA (exoRNA) And Cell-Free DNA (cfDNA) Isolation And Analysis 11/19/2014 11:57:10 AM
Exosome Diagnostics Announces Appointment Of Thomas Mclain As Chief Executive Officer 8/4/2014 7:24:15 AM
Exosome Diagnostics Announces Appointment of Vincent J. O'Neill, M.D. As Chief Medical Officer 6/3/2014 6:37:21 AM
Exosome Diagnostics Announces Appointment Of William J. Kelly As Chief Financial Officer 5/28/2014 7:03:37 AM
Exosome Diagnostics Scores $27 Million To Launch Prostate Lab Test 3/11/2014 6:17:18 AM